<DOC>
	<DOCNO>NCT00659386</DOCNO>
	<brief_summary>Rationale : Parvovirus B19 ( PVB19 ) persistence heart associate progressive cardiac dysfunction evolution dilate cardiomyopathy . Objective : Whether high dose intravenous immunoglobulin ( IVIg ) addition conventional heart failure therapy achieve virus reduction , thereby result improvement cardiac function . Study design : A interventional study virus presence cardiac functional capacity IVIg therapy . Study population : Patients idiopathic cardiomyopathy symptomatic heart failure 1 year significant PVB19 viral load endomyocardial biopsy ( EMB ) treat high dose IVIg include . Intervention ( applicable ) : Patients treat total dose 2 g/kg immune globulin administer 0.5 g/kg IV period 6 hour 4 consecutive day . Main study parameters/endpoints : EMBs : virus ( PVB19 , enteroviruses , adenovirus , Epstein-Barr virus , human herpes virus-6 cytomegalovirus ) , inflammation ( lymphocytes macrophage ) fibrosis . Cardiac functional capacity : NYHA classification , echocardiographic evaluation ( left ventricular ejection fraction , end-systolic diameter , end-diastolic diameter ) .</brief_summary>
	<brief_title>IVIg Therapy Patients With Idiopathic Cardiomyopathy Endomyocardial Biopsy Proven High PVB19 Viral Load</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Idiopathic heart failure &lt; 1 year . Optimal conventional heart failure medication &lt; 6 month . PVB19 viral load &gt; 150copies/mcg DNA EMBs . significant ( lesion &gt; 50 % stenosis ) coronary artery disease . significant valvular disease . systemic disease sarcoidosis , giant cell myocarditis , hemochromatosis , systemic autoimmune disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Parvovirus B19</keyword>
	<keyword>Intravenous immuneglobulin</keyword>
</DOC>